Earnings Data Deluge

Following yesterday's Personal Consumption Expenditures (PCE) and Wednesday's Fed meeting and press conference with Fed Chair Kevin Warsh, we quiet down ahead of the final trading session for the week. Despite some mid-week turbulence, we're trading fairly even with where we were as of mid-day Monday. The Dow is +179 points at this hour, the S&P 500 +12 and the Nasdaq +241 points.

Q2 Employment Costs are out this morning, but unlikely to move the needle in terms of trading sentiment. The headline +0.9% matches the previous quarter and +10 basis points (bps) from expectations. Wages and salaries for civilian workers came in at +3.2%, benefits +3.8%. For state and local government workers, this adjusts to +3.6%.

Q2 Earnings at a Glance: ABBV, XOM & More

AbbVie (ABBV) shares are trading down at this hour, following a beat by a penny on the bottom line to $3.65 per share on revenues of $16.99 billion, +1.07%. The Big Pharma staple has not missed on earnings since 2018. But full-year earnings guidance was pulled lower than current projections, and shares are down -4% presently.

A pair of International Integrated Oil & Gas "supermajors" also reported earnings this morning. ExxonMobil (XOM) posted a negative earnings surprise of -4.35% on lower quarterly oil production, for its second miss in the past four quarters. Chevron (CVX) beat estimates by +4.48%. Both companies blasted past revenues estimates by +21%, though only Chevron is trading higher.

Colgate-Palmolive (CL) outpaced earnings estimates, $0.99 per share versus $0.95, even though higher tariff costs dampened the household products major's outlook. Revenues were fairly in-line with estimates at $5.36 billion, above the $5.11 billion reported a year ago. Shares are down -1.8% at this hour.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Chevron Corporation (CVX) : Free Stock Analysis Report

ExxonMobil Holdings Corporation (XOM) : Free Stock Analysis Report

Colgate-Palmolive Company (CL) : Free Stock Analysis Report

AbbVie Inc. (ABBV) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

View Comments